Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

The role of Ca2+-activated K+ channels in bronchorelaxation by NKH-477

March 17, 1998

First market introduction for Allegra-D

March 16, 1998

Hoechst Marion Roussel and 3M establish marketing agreement for asthma products

March 13, 1998

Milkhaus receives patent protection for DNA treatment of respiratory disorders

March 13, 1998

Interim safety data reported for Procysteine

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

First launch for Synthelabo antihistamine

March 11, 1998

Clinical syndromes associated with zafirlukast therapy in patients with asthma

March 10, 1998

Yamanouchi engages in NK antagonist research

March 6, 1998

U.K. market introduction for Singulair

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.